Home » Topics » Regulatory » Patents

Patents
RSS

Bayer describes BUB1 inhibitors for cancer

Jan. 13, 2017

Servier and Vernalis jointly patent Mcl-1 inhibitors

Jan. 13, 2017

Chongqing University reports PDE5A inhibitors

Jan. 13, 2017

FASN inhibitors reported in Teva patent

Jan. 13, 2017

Kissei Pharmaceutical describes TRPM8 antagonists

Jan. 12, 2017

Takeda reports M1 PAMs for Alzheimer's disease

Jan. 12, 2017

Bayer patents anticancer compounds

Jan. 12, 2017

Apodemus prepares and tests PI4Kbeta inhibitors

Jan. 11, 2017

Actelion Pharmaceuticals reveals NOX4 inhibitors for fibrosis

Jan. 11, 2017

Novartis describes SHP-2 inhibitors

Jan. 11, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....